Wei Yuquan

Academician

Chinese Academy of Sciences

Deng Zixin

Academician

Chinese Academy of Sciences

Chen Kaixian

Academician

Chinese Academy of Sciences

Wang Yue

Managing Director

China Society for Drug Regulation

Zhang Lianshan

Vice President & President of Global R&D

Hengrui Pharmaceuticals

Fang Jianmin

CEO & CSO

RemeGen

Li Ning

General Manager

Junshi Pharma

Zhang Wenjie

Chairman, Executive Director, CEO

Henlius

Gong Zhaolong

Chairman & CEO

3D Medicines

Tao Weikang

Via president & General manager of Innovative Drug

Qilu pharmacentical

Xu Ting

President

Alphamab Oncology

Sui Ziye

Executive Director and General Manager

Lepu Biopharma

Yang Jianxin

CEO

CStone Pharmaceuticals

Yang Qing

Co-CEO

WuXi AppTec

Li Yiping

CEO

JW Therapeutics

Huang Hai

CEO & Executive President

Fosun Kite

Huang Ying

CEO

Legend Biotech

Li Zonghai

Co-founder & CEO & CSO

CARsgen Therapeutics

Li Bin

Founder, Chairman & CEO

Neurophth

Wang Jianxiang

Deputy Director, Hematology Hospital, Institute of Hematology

Chinese Academy of Medical Sciences

Liang Zicai

CEO

Ribo Life Science

Ying Bo

Founder & CEO

ABOGEN

Lu Yang

CEO

Sirnaomics

Wang Zefeng

Scientific Founder

CirCode

Wang Hualiang

President

Shanghai Institute of Experimental Medicine

Cai Daqing

Founding Managing Partner

Sherpa Healthcare Partners

Wang Junfeng

Co-Chief Investment Officer & Managing Director

Legend Capital

Cai Yuan

CEO

Starry

Bai Jian

Director of Bioinformatics

Berry Oncology

Gui Xun

Head of Innovation Discovery Department

Mabwell

Guo Jingjing

Director of Translational Medicine

Iaso Bio

Han Dongmei

Deputy General Manager of Product Development

Henlius

Jiang Yuhang

Deputy Director

ABOGEN

Huang Jinyu

Vice President of Chemistry

Rona Therapeutics

Jin Xiumei

Senior Director, Head of QA

FutureGen

Lin Jialiang

Senior Researcher of Nucleic Acid Innovation Institute, Senior Engineer

Haichang Biotech

Lu Yuan

Director

Hrain Biotechnology

Liu Jia

Vice President of Research Institute

China Resources Bio-pharmaceuticals

Li Dong

General Manager, Shanghai R&D Center

RemeGen

Miao Xiaoniu

Director of Antibody Discovery and Modification

Biotheus

Peng Jianjian

Senior R&D Manager

Alphamab Oncology

Qin Lan

Senior Director, Clinical Study Department

3D Medicines

Sun Jingwei

R&D Director

GRIT Biotechnology

Shi Hui

Director of Clinical Medicine & Managing Partner

Allife Medicine

Yang Qingliang

Technical Director

DAC BIOTECHNOLOGY

Yuan Han

Head of CAR-NK R&D

Innovent Cells Pharmaceuticals

Yuan Ye

Senior Director

Henlius

Wang Min

Vice President

PersonGen

Zhang Jiqin

Vice President of R&D

BRL Medicine

Zhang Yujie

Director of Analysis

BeiGene